icotec AG gains critical NTAP approval for its CMORE-CT spinal implant system, positioning the firm for increased Medicare-funded adoption and revenue growth starting in late 2026.
The Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-on Payment (NTAP) status to icotec's CMORE-CT system, effective October 1, 2026. This regulatory milestone is expected to significantly broaden patient access to the company's radiolucent spinal stabilization technology by providing additional reimbursement for Medicare-eligible procedures.
The NTAP status becomes effective on October 1, 2026.
It expands access to icotec's radiolucent spinal stabilization technology by facilitating reimbursement for Medicare-eligible procedures.
The Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-on Payment (NTAP) status to icotec AG's CMORE-CT spinal stabilization system. This regulatory milestone, effective October 1, 2026, significantly expands patient access to the company's radiolucent technology for Medicare-covered procedures.
The NTAP status allows for additional Medicare payments for the use of the CMORE-CT system, incentivizing hospitals to adopt the technology for spinal procedures.